AcquisitionOther
Jade Biosciences, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Jade Biosciences, Inc. -> target · $300 Million
Jades pipeline also includes two undisclosed antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development.
Open source record (SEC) ↗